Various new developments and performance metrics highlight **Emerson Electric's (EMR)** position in the market. The company has been attracting significant **investor attention** due to consistently beating stock market upswings. Despite selling substantial shares, **Epoch Investment Partners** and **Inspire Investing** have reduced their positions, while **Newport Trust Company**, **Gardner Lewis Asset Management**, and **Waycross Partners LLC** have taken positions. Notwithstanding the potential weak financials underlying EMR's recent performance, **analysts** hold a consensus of 'Moderate Buy' for the stock and even suggest strong prospects. However, note that EMR missed its Q2 sales targets, and Morgan Stanley initiated its coverage with an underweight recommendation. Nevertheless, EMR's Q2 and Q3 2024 earnings beat estimates and registered a Y/Y sales rise. Analysts and brokers deem **Emerson Electric** a good investment, particularly its value for the long-term, and its stock has been viewed as undervalued. It has outperformed market returns, rewarded with a dividend of $0.525, and has been rated a 'top dividend aristocrat'. Despite showing mixed market performance, industry experts and investors foresee a turnaround, especially with the stocks showing improved relative strength. EMR's commitment to continued innovation in the various business sectors strengthens its portfolio, backed by increased insider bullish bets and robust growth
Emerson Electric EMR News Analytics from Sun, 24 Mar 2024 07:00:00 GMT to Sun, 22 Sep 2024 15:27:19 GMT -
Rating 8
- Innovation 6
- Information 7
- Rumor -2
